![]() |
市场调查报告书
商品编码
1729632
日本伤口护理市场规模、份额、趋势及预测(按产品类型、伤口类型、最终用户和地区),2025 年至 2033 年Japan Wound Care Market Size, Share, Trends and Forecast by Product Type, Wound Type, End User, and Region, 2025-2033 |
2024 年,日本伤口护理市场规模价值 7.4571 亿美元。展望未来, IMARC Group估计到 2033 年市场规模将达到 11.2743 亿美元,2025 年至 2033 年的复合年增长率为 4.30%。市场的主要驱动因素是糖尿病等慢性病的盛行率不断上升、伤口护理技术的进步、感染控制意识的不断增强、医疗支出的增加、政府改善医疗基础设施的倡议以及向微创治疗的转变,这些都促进了市场的强劲增长。
日本市场主要受到糖尿病和肥胖症等生活方式疾病发病率上升的推动,这进一步增加了慢性伤口的发病率,因此对有效的伤口管理解决方案的需求持续增加。日本人口老化主要影响了压疮和糖尿病足溃疡等慢性伤口盛行率的增加,从而增加了对先进伤口护理产品的需求。此外,日本医疗基础设施的改善以及医疗技术投资的增加使得市场不断扩大。例如,日本厚生劳动省于2024年8月26日公布了“全球健康愿景2024”,旨在透过创新、公平获得医疗保健和加强国际合作来应对全球健康挑战。该策略优先考虑大流行病防范、卫生系统復原力和推动全民健康覆盖。它加强了日本作为全球卫生领域领导者的地位,服务于联合国永续发展目标。
此外,医疗保健提供者和患者对先进伤口护理产品比传统方法具有更好效果的认识不断提高,进一步扩大了市场渗透率。除此之外,政府发起的旨在提供更好的医疗保健服务的计划和加强伤口护理产品的报销政策促进了市场成长。主要产业参与者更加重视研发 (R&D) 活动,从而加快了符合日本民众需求的新时代产品的推出速度,从而推动了市场的发展。例如,2024 年 3 月 13 日,日本研究人员设计了一种新时代的生物电子伤口敷料,将水凝胶与微电子技术相结合,以促进更快的癒合并最大限度地减少感染的机会。这项创新可以监测伤口环境并提供精确的电刺激,增强组织修復。这项突破凸显了日本在融合生物技术和电子技术以应对医疗保健挑战方面的领导地位。
先进伤口护理产品的采用率不断提高
水凝胶、水胶体和银基敷料等先进伤口护理产品的普及,支持了日本整体伤口护理市场的成长。 2024 年 6 月发表在《临床与转化研究杂誌》上的一项研究调查了一种含有银奈米颗粒的新型敷料对慢性溃疡的有效性。这种先进的敷料可以使伤口癒合速度比平常快几倍,并可以作为伤口慢性管理的新概念带来有希望的结果。与常见的伤口护理产品相比,此类产品具有更好的保湿性和抗菌作用。因此,由于日本医疗保健提供者希望患者获得更好的治疗效果,对先进伤口护理产品的需求预计会增加。希望尽量减少医疗相关感染并实现快速治愈,这促使人们专注于提供感染控制和组织再生等高级功能的产品。
远距医疗和数位工具的作用日益增强
日本一直在投资数位健康技术,包括远距医疗平台、行动健康应用程式和伤口护理监测系统。这些工具使患者能够接受远端咨询,监测伤口癒合过程并获得及时介入。医疗保健提供者可以透过数位平台有效地管理多名患者,提高护理的可近性和连续性,特别是对于农村地区的患者或行动不便的老年患者。这从整体上改善了患者护理并优化了治疗结果。例如,2024 年 6 月 4 日,Infosys 和日本最大的配药连锁店 Nihon Chouzai 宣布合作,透过尖端的线上药物增强日本的医疗保健服务。作为合作的一部分,Infosys 设计了 NiCOMS,这是一款行动远距医疗应用程序,允许患者从註册药剂师那里获得远端用药指导,从而无需他们亲自前往药房。
个人化伤口护理解决方案的兴起
个人化伤口护理解决方案的兴起,满足了患者的个人需求,极大地影响了日本伤口护理市场份额。随着生物技术和再生医学的进步,生物工程皮肤替代品和负压伤口治疗系统等产品越来越受欢迎。例如,2024年4月1日,在日本拥有超过25年经验的着名医疗器材製造商Smith+Nephew推出了用于家庭慢性伤口护理的RENASYS EDGE负压伤口治疗系统。此紧凑系统的设计旨在为患者提供舒适感和易用性,同时确保有效的治疗。透过与 SunMED 和 First Nation Group 合作,该系统的可用性将扩展到美国各地。这些产品透过刺激组织再生和解决特定伤口类型(例如糖尿病溃疡或烧伤)来促进更快的伤口癒合。对于治疗慢性和不癒合伤口,传统方法可能效果较差,因此这种方法尤其有价值。
The Japan wound care market size was valued at USD 745.71 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 1,127.43 Million by 2033, exhibiting a CAGR of 4.30% from 2025-2033. The market is primarily driven by increasing prevalence of chronic conditions like diabetes, advancements in wound care technologies, growing awareness about infection control, rising healthcare spending, government initiatives to improve healthcare infrastructure, and a shift towards minimally invasive treatments, contributing to the market's robust growth.
The market in Japan is majorly driven by the increased incidence of lifestyle diseases, including diabetes and obesity, which has further increased the incidence of chronic wounds, creating a continued need for effective wound management solutions. The aging population in Japan primarily influences the increased prevalence of chronic wounds, such as pressure ulcers and diabetic foot ulcers, consequently increasing demand for advanced wound care products. Further, the improvement of healthcare infrastructure in Japan, along with increased investments in medical technology, makes the market expand. For instance, on August 26, 2024, Japan's Ministry of Health, Labour and Welfare announced its "Global Health Vision 2024," aiming at addressing global health challenges through innovation, equitable access to healthcare, and strengthened international collaboration. This strategy prioritizes pandemic preparedness, health system resilience, and advancing universal health coverage. It strengthens Japan's stance as the leader in global health to serve the United Nations Sustainable Development Goals.
Moreover, increasing awareness among healthcare providers and patients about superior results in advanced wound care products compared to conventional methods further develops market penetration. Apart from that, government-initiated programs aimed at making better health care services available and enhanced reimbursement policies for wound care products promote market growth. Increased focus on research and development (R&D) activities by key industry players increases the rate of new-age product launches aligned to the requirements of the Japanese population, hence also driving the market. For instance, on March 13, 2024, Japanese researchers designed a new age bioelectronic wound dressing, combining hydrogel with microelectronics, to facilitate faster healing with minimal chances of infection. This innovation monitors the wound environment and delivers precise electrical stimulation, enhancing tissue repair. The breakthrough highlights Japan's leadership in merging biotechnology and electronics to address healthcare challenges.
Increased Adoption of Advanced Wound Care Products
The increased adoption of advanced wound care products, such as hydrogels, hydrocolloids, and silver-based dressings, supports the overall Japan wound care market growth. A study published in June 2024 in the Journal of Clinical and Translational Research examined the effectiveness of a new dressing containing silver nanoparticles for chronic ulcers. This advanced dressing heals the wound up to several fold times faster than usual and can offer promising results as a new concept in the chronic management of wounds. Such products offer greater retention of moisture and better antimicrobial action than common wound care products. Therefore, demand for advanced wound care products is expected to rise as Japanese healthcare providers want better results from patients. The desire to minimize healthcare-associated infections and achieve quick healing is motivating to focus on products that offer advanced functionalities like infection control and tissue regeneration.
Growing Role of Telemedicine and Digital Tools
Japan has been investing in digital health technologies, which include telemedicine platforms, mobile health applications, and wound care monitoring systems. These tools enable patients to receive remote consultations, monitor their wound healing process, and gain timely interventions. Healthcare providers can manage several patients through digital platforms efficiently, enhancing accessibility and the continuity of care, especially for patients in rural areas or elderly patients who have mobility problems. This improves patient care in general and optimizes the outcomes of treatments. For example, on June 4, 2024, Infosys and Nihon Chouzai, the biggest dispensing pharmacy chain in Japan, announced a collaboration to enhance healthcare access in Japan through cutting-edge online medication. As a part of this partnership, Infosys designed NiCOMS, a mobile telemedicine application that allows patients to receive remote medication guidance from registered pharmacists, thus not requiring them to visit pharmacies in person.
Rise of Personalized Wound Care Solutions
The rise of personalized wound care solutions, which cater to the individual needs of patients, significantly influences the Japan wound care market share. With advancements in biotechnology and regenerative medicine, products such as bioengineered skin substitutes and negative pressure wound therapy system are gaining popularity. For example, on April 1, 2024, Smith+Nephew, a prominent medical device manufacturer with over 25 years of experience in Japan, launched the RENASYS EDGE Negative Pressure Wound Therapy System for home-based chronic wound care. The compact system is designed for patient comfort and ease of use while ensuring effective treatment. Through partnerships with SunMED and First Nation Group, the system's availability will be expanded across the U.S. These products promote faster wound healing by stimulating tissue regeneration and addressing specific wound types, such as diabetic ulcers or burns. Such options are especially valued in the treatment of chronic and non-healing wounds, where traditional methods may be less effective.
Advanced wound care products, such as hydrocolloids, foams, alginates, and hydrogels are some of the major products that contribute to Japan wound care market. They are preferred for managing chronic and complex wounds as they maintain a moist healing environment, reduce infection risks, and improve healing efficiency. The increasing trend of the geriatric population, along with rising diabetes and venous diseases, will drive demand in Japan for such innovative solutions. Growth in the market is further seen due to advancements in technologies related to negative pressure wound therapy and bioengineered skin substitutes.
Surgical wound care products include sutures, staples, adhesives, and surgical dressings, among others. Being a country that is advanced in terms of medical infrastructure, Japan has a high rate of surgical procedure performance. All these products ensure the proper closure of the wound immediately after surgery. The innovative development of surgical technology, including the use of laparoscopic and robotic procedures, increases demand for specialized wound closure solutions. Investment in antimicrobial and absorbent dressings is further emphasized by the need for infection prevention and quicker recovery, as this aligns with Japan's emphasis on minimizing healthcare-associated complications and enhancing overall care standards.
Traditional wound care products, such as gauze, cotton, and bandages, remain a staple in Japan's wound care market due to their affordability and widespread availability. These products are typically used for minor injuries and home-based care, especially in rural or resource-poor settings. Although the shift towards advanced wound care solutions is increasing, traditional products remain significant in the market. Their cost-effectiveness makes them an attractive choice for basic wound management, especially for less severe cases, ensuring they maintain relevance alongside newer technologies.
Chronic wounds, such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers, represent a significant area of focus in Japan's wound care market due to the aging population. These wounds require advanced therapy with a long time for healing and, therefore, demand NPWT, advanced dressings, and biological products. In addition, the growing prevalence of diabetes and vascular diseases is on the increase and will increase demand for innovative solutions. The emphasis on reducing healthcare expenditure and improving patient outcomes results in better chronic wound management and serves as a rationale for investment in research, new product development, and access to treatments.
Acute wounds resulting from surgical procedures, trauma, or burns are a crucial segment in Japan's wound care market. Acute wounds are associated with high levels of risk and may result in complications if proper treatment is not received on time. It requires treatment through antimicrobial dressings, sutures, staples, and surgical sealants. Due to Japan's advanced development of minimally invasive surgical techniques, there has also been an increase in acute wound products. The country's commitment to high standards of healthcare and the efforts to integrate advanced technologies into wound management practices support the growth of the market.
Hospitals and clinics play a significant role in Japan's wound care market, as they handle complex and acute cases. Hospitals and clinic facilities are well-equipped with diagnostic tools and have highly skilled medical professionals who ensure proper wound management. Most patients with severe injuries, surgical wounds, and chronic conditions such as diabetic ulcers are treated in these facilities. The availability of advanced technology and specialized wound care units in hospitals allows for newer therapy modalities, such as negative pressure wound therapy and bioengineered skin substitutes, to be adopted in growing this market and improving patient outcomes.
Long-term care facilities in Japan are significant for patients with chronic conditions requiring ongoing wound management. Pressure ulcers and diabetic foot ulcers are common among the residents, so prevention and treatment strategies must be effective. These facilities focus on cost-effective wound care products such as hydrocolloid dressings and antimicrobial solutions that bring long-term benefits. Training programs for staff in wound care enhance the quality of services. Long-term care facilities contribute to the changing wound care industry by making specialized goods more in demand as the need for geriatric care keeps growing.
Home care settings assume importance in the wound care market of Japan with the growing need for outpatient and home-based care among the geriatric population. Products like foam dressings, alginate dressings, and portable wound care devices are fast gaining popularity because they are convenient and effective. Home care services minimize hospitalization expenses but allow the patient to return home and enjoy the comfort of their surroundings, enhancing their quality of life. The increased availability of telemedicine also aids this trend by allowing monitoring and guidance remotely by healthcare providers. This shift is in alignment with home-based care policies set by the government and is expected to fuel demand for wound care products in this market segment.
The market in Japan is highly competitive and driven by the advanced healthcare infrastructure, an aging population, and increasing chronic conditions such as diabetes. Companies are focused on innovative solutions such as hydrocolloids, foam dressings, and bioactive products to address complex wounds. The collaboration between healthcare providers, research institutions, and manufacturers drives product development and clinical efficacy. Emerging trends in digital health integration are smart dressings with monitoring capabilities, among others. Strict regulatory standards and the need for cost-effective, high-quality solutions further shape the market. The growth is further supported by increased healthcare spending and expanded wound care education initiatives.
The report provides a comprehensive analysis of the competitive landscape in the Japan wound care market with detailed profiles of all major companies.